#PFO & ASD Closure

[drrichardzelman]

Dr Richard Zelman's Toolkit - Navigating Modern Cardiac Therapies

A Pioneer in Modern Cardiac Practices: Dr Zelman's Impact on Community Hospitals

At the forefront of these advancements stands Dr Richard Zelman, a pioneer in his field. His dedication to innovation and adoption of novel therapies has expanded the boundaries of cardiology, particularly in the realm of interventional procedures. Groundbreaking in his approach, Dr. Zelman has been instrumental in launching cardiac programs in Massachusetts and has been recognized for his remarkable outcomes in structural heart and vascular procedures. His contributions to research and his commitment to enhancing patient care have left an indelible mark on the field of cardiovascular medicine.

The realm of cardiac therapies has undergone a paradigm shift, moving beyond conventional approaches towards more targeted and personalized interventions. Advancements in diagnostic technologies and a nuanced understanding of the underlying molecular and genetic factors have paved the way for a new era in cardiovascular medicine.

One of the groundbreaking developments in modern cardiology is the integration of genomic medicine into diagnostic and therapeutic strategies. The ability to analyze an individual's genetic makeup provides cardiologists with invaluable insights into the patient's susceptibility to certain cardiac conditions and their response to specific treatments. This personalized approach allows for the tailoring of interventions, optimizing outcomes and minimizing adverse effects.

Precision therapies, guided by genetic information, enable cardiologists to target the root causes of cardiovascular diseases at a molecular level. This approach holds immense promise for conditions that were once considered challenging to treat effectively. As we move forward, the integration of genomics into routine cardiac care is poised to become a standard practice, revolutionizing the way cardiologists diagnose and treat various cardiovascular disorders.

Interventional Cardiology: Beyond Traditional Boundaries

Dr Richard Zelman MD has witnessed and contributed to the transformative changes within this specialty. There has been a significant shift towards minimally invasive procedures over traditional open-heart surgeries. These procedures, often performed through small incisions or catheters, not only mitigate the risks associated with surgery but also reduce recovery times and enhance overall patient outcomes.

Minimally invasive interventions, such as percutaneous coronary interventions (PCI) and transcatheter aortic valve replacement (TAVR), have become pivotal in the management of coronary artery disease and valvular heart disorders. These techniques, guided by advanced imaging technologies, allow cardiologists to navigate the intricate pathways of the cardiovascular system with precision, promoting quicker recovery and improved quality of life for patients.

The field of interventional cardiology has expanded beyond the confines of coronary interventions to address structural heart abnormalities. Structural heart interventions, including atrial septal defect (ASD) and patent foramen ovale (PFO) closures, showcase the versatility of modern cardiac therapies. These interventions, often performed with catheter-based techniques, offer alternatives to traditional surgical approaches, presenting less risk and faster recovery.

The advent of transcatheter mitral valve repair and replacement represents a significant leap forward in the treatment of mitral valve disorders. These procedures, performed without the need for open-heart surgery, provide viable options for patients who may not be suitable candidates for traditional valve replacement. The expanding repertoire of structural heart interventions exemplifies the dynamic nature of interventional cardiology and its capacity to address a diverse range of cardiac conditions.

Pharmacotherapy in Cardiovascular Medicine

Dr Richard Zelman has been at the forefront of these advancements, integrating emerging pharmacological agents into his practice. Novel anticoagulants and antiplatelet therapies are revolutionizing the prevention and treatment of conditions like atrial fibrillation and acute coronary syndromes. His understanding of pharmacotherapy has played a significant role in his successful management of cardiovascular diseases.

The integration of RNA-based therapies represents a futuristic frontier in pharmacology. RNA-based drugs hold the potential to modulate gene expression, offering targeted treatment approaches for a variety of cardiovascular disorders. As research in this field progresses, cardiologists may soon have access to a new class of medications that can address the root causes of diseases at a molecular level, further refining treatment strategies.

The Intersection of Technology and Cardiac Care

Dr Richard Zelman fully recognizes how technology has become an integral part of modern healthcare, and cardiology is no exception. Digital health solutions and remote monitoring tools are empowering cardiologists to monitor patients' cardiac health in real-time, allowing for proactive intervention and personalized care plans. Wearable devices, equipped with sensors and connectivity features, enable continuous tracking of vital signs, providing valuable data for early detection of potential cardiac issues.

Telemedicine has emerged as a game-changer, facilitating virtual consultations and follow-ups. This approach not only enhances accessibility to cardiac care but also ensures that patients receive timely guidance on managing their conditions. The integration of artificial intelligence (AI) algorithms into diagnostic processes further augments the capabilities of cardiologists, enabling more accurate and efficient interpretation of medical imaging and diagnostic tests.

Challenges and Future Directions

While the modern cardiologist's toolkit is vast and sophisticated, challenges persist. The integration of these advanced therapies into routine clinical practice requires ongoing education and training for healthcare professionals. Additionally, the economic considerations associated with adopting cutting-edge technologies and therapies pose challenges for healthcare systems globally.

Looking ahead, the field of cardiology is poised for continued growth and innovation. Research into regenerative medicine, stem cell therapies, and further exploration of the microbiome's impact on cardiovascular health hold the promise of unlocking new frontiers in cardiac care. As our understanding of cardiovascular diseases deepens, and technological advancements continue to accelerate, the cardiologist's toolkit will undoubtedly evolve, providing new avenues for the prevention, diagnosis, and treatment of heart-related disorders.  

Dr Richard Zelman’s toolkit reflects the dynamic and multidimensional nature of cardiovascular medicine. From precision therapies guided by genomics to minimally invasive interventions and the integration of digital health solutions, this toolkit equips cardiologists with a diverse array of strategies to navigate the complex landscape of cardiac care. As the field continues to advance, the collaboration between technology, pharmacology, and clinical expertise will undoubtedly drive further innovations, ultimately enhancing patient outcomes and shaping the future of cardiology.

[indiamedicaltourism]

Top ASD Surgery Surgeons in India

A foetal heart defect known as an atrial septal defect (ASD) forces blood to circulate across the heart's atria (upper chambers). A patent (open) foramen ovale (PFO) is a situation where the foramen ovale fails to normally be closed after birth. Partial flow is expected before birth and soon after delivery through the foramen ovale. Patients who have a spontaneous atrial septal aneurysm (ASA) frequently suffer from it.

The interatrial septum, which splits the atria after PFO closure, generally acts as this wall. If this septum fails or is weakened, oxygen-rich blood can pass straight up from the left flank of the heart to the reverse part of the heart's oxygen-deficient blood, or vice versa, based on which atrium has the greater blood pressure. The pressure in the left atrium rises when there are no further cardiac dysfunctions. As a result, the arterial blood which sustains the brain, tissues, and organs may have lower-than-normal oxygen levels. However, an ASD may not show any apparent signs or indications, especially since the abnormality is tiny. Additionally, compared to the entire population, those who have suffered a cryptogenic stroke are more inclined to be diagnosed with a PFO.This medical condition may lead to cardiac failure if left untreated because it can cause the opposite side of the heart's chambers to expand.

ASD Surgery Cost in India

ASD Surgery price in India can range from something around INR 278,000 to 437,000 INR. Compared to the US, the prices are less than 20%. When compared to various other countries, cost of ASD Surgery in India is really inexpensive. The total price of ASD Surgery in India is determined by several of variables and could differ within a certain range.

Best ASD Surgery Hospitals in India

India has a high standard regarding its hospitals. The best hospital for ASD Surgery in India undergoes periodic checks to verify their pristine condition and the modernity and maintenance of their equipment. These hospitals employ some of the most highly skilled medical professionals in the world who are experts in their fields. If you are seeking for a hospital in India, you are in safe hands. You will get the best care and treatment in a price equal to very less as compares to foreign countries. SevenHills Hospital, Aster Medcity and Apollo Hospital are some of the best ASD Surgery hospital in India.

Best ASD Surgery Doctors in India

India is full of qualified doctors. The Best ASD Surgery doctors in India are highly skilled and qualified in heart disease treatment and have higher experience and know all the stuff about this operation from the core. Dr. Amit Misri, Dr. Shipra Srivastava and Dr.Robert Coelho are some of the Best Doctors for ASD Surgery in India.

Al Afiya Medi Tour is a well-known health tourism company in India. We are offer medical tourism services in India foreign patients. Some of the main countries are Bangladesh, South Africa, Uganda, Zambia, Namibia, Iraq, Kenya, Nigeria and so on. We provide free assistance for TURP surgery cost in India, lung cancer treatment, stomach cancer treatment in India, liver transplant cost in India, best hospital for heart valve replacement, bone marrow transplant cost in India, arthroscopic surgery, best liver transplant hospital in India, brain tumor surgery cost in India, kidney transplant in India, liver cancer treatment, best bone marrow hospital in India etc.  If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Alafiyameditour.com.

Source: https://alafiyameditour1.blogspot.com/2023/11/top-asd-surgery-surgeons-in-india.html

[cardiologist-1589254]

Minimally Invasive Approaches to Correcting Congenital Heart Defects

Congenital heart defects are structural abnormalities present at birth that affect the heart's structure and function. Fortunately, advances in medical technology have paved the way for minimally invasive approaches to correct these defects, offering numerous benefits to patients, especially children.

Key Minimally Invasive Techniques:

Cardiac Catheterization: This procedure involves threading a catheter through a blood vessel to reach the heart. Through catheterization, holes in the heart, narrowed blood vessels, and abnormal heart valves can often be repaired without open-heart surgery.

Transcatheter Procedures: Transcatheter interventions have become the gold standard for treating certain congenital heart defects. For example, transcatheter atrial septal defect (ASD) or patent foramen ovale (PFO) closure is a common procedure that involves sealing a hole in the heart's wall to prevent abnormal blood flow.

Balloon Angioplasty: This technique is used to widen narrowed heart valves or blood vessels. A balloon-tipped catheter is inserted into the narrowed area and inflated to expand the vessel or valve, improving blood flow.

Stent Implantation: In some cases, a stent (a small mesh tube) is placed during catheterization to maintain the patency of blood vessels or valves. Stents are especially useful in treating narrowed pulmonary arteries or aortic coarctation.

Benefits of Minimally Invasive Approaches:

Less Trauma: Minimally invasive procedures involve smaller incisions or no incisions at all, leading to less physical trauma to the body.

Faster Recovery: Patients typically experience shorter hospital stays and quicker recovery times compared to traditional open-heart surgery.

Reduced Scarring: Minimally invasive approaches result in smaller scars or no visible scars, which can be especially important for pediatric patients.

Lower Infection Risk: The reduced exposure of internal organs minimizes the risk of post-operative infections.

Less Pain: Patients often experience less post-operative pain with minimally invasive techniques.

Improved Cosmetic Outcomes: The aesthetic benefits of smaller incisions are particularly appreciated by pediatric patients and their families.

Minimally invasive approaches have revolutionized the treatment of congenital heart defects, offering safer and more effective alternatives to traditional open-heart surgery. These techniques have significantly improved the quality of life for patients, particularly children, allowing them to lead healthier and more normal lives after corrective procedures. Consulting with a cardiologist near you can help determine the most appropriate approach for each individual's specific congenital heart defect.

[severepeanutperfection]

Transseptal Access Systems Market Key Players, Industry Overview, Applications and Analysis 2032

The Transseptal Access Systems Market is a specialized sector within the medical device industry that focuses on devices and tools used to access the left atrium of the heart through the interatrial septum, a thin wall that separates the heart's upper chambers. Transseptal access is a critical procedure in various cardiovascular interventions, including catheter-based ablation for arrhythmias, structural heart procedures like atrial septal defect (ASD) and patent foramen ovale (PFO) closure, as well as left atrial appendage occlusion to reduce the risk of stroke in atrial fibrillation patients. The market for these systems has witnessed substantial growth due to the increasing prevalence of cardiovascular diseases and the expanding array of minimally invasive cardiac procedures.

One of the key drivers of growth in the Transseptal Access Systems Market is the rising incidence of atrial fibrillation (AF), a common cardiac arrhythmia. As AF is associated with an elevated risk of stroke, patients often require interventions like left atrial appendage occlusion, which necessitates transseptal access. Furthermore, advancements in catheter-based therapies for structural heart conditions, such as ASD and PFO closures, have expanded the applications of transseptal access systems. The market has responded with innovations in device design and improved safety profiles, making these procedures more accessible and less invasive for patients.

The Transseptal Access Systems Market also benefits from ongoing technological advancements. Novel catheter designs, real-time imaging technologies, and navigation systems have significantly improved the precision and safety of transseptal procedures. These innovations not only enhance the overall patient experience but also reduce the procedural risk for physicians. Additionally, the market is witnessing a shift towards the development of integrated systems that offer comprehensive solutions for transseptal access, further simplifying and streamlining these complex procedures.

For More Info@ https://www.prnewswire.com/news-releases/transseptal-access-systems-market-is-projected-to-grow-at-a-cagr-of-104-during-2017-to-2025---persistence-market-research-665416633.html

Despite the positive growth prospects, the market faces challenges related to safety and the learning curve for physicians adopting these procedures. Ensuring the proper training and proficiency of healthcare professionals using transseptal access systems is crucial to minimizing complications and optimizing patient outcomes. Regulatory and reimbursement hurdles also need to be addressed to ensure widespread adoption of these devices. In conclusion, the Transseptal Access Systems Market is expected to continue its expansion, driven by the increasing prevalence of cardiovascular diseases, technological innovations, and the growing acceptance of minimally invasive cardiac procedures.

[hhsmumbai]

Best Cardiologist in Mumbai | Heart Specialist in Mumbai

Our new Structural Heart and Valve Clinic is a one-stop solution for various heart valve problems, assuring you of better heart health and a better quality of life. The treatment options offered by our expert cardiologists include: - Percutaneous Mitral Valve Replacement (TMVR) - Transcatheter Aortic Valve Replacement (TAVR) - MitraClip - Tricuspid Valve Replacement (Tric Valve) - Transpulmonary pulmonary valve replacement - Balloon Valvuloplasty - Balloon Mitral valvotomy (BMV) - ASD/VSD closures - PFO Closures - Left Atrial Appendage Ligation/Closure To get in touch with our team, dial (022 - 4510 8989 / 6154 8989)

[bestinterventionalcardiologist]

The Top Cardiac Surgeon in Hyderabad: What Sets Them Apart from the Rest

Best Cardiac Surgeon in Hyderabad

Welcome to our comprehensive guide on Dr. Sudheer Koganti, the best cardiologist in Gachibowli and Hyderabad. As one of the most trusted heart specialists in the region, Dr. Sudheer Koganti has been providing top-notch cardiac care to his patients for years.

At our clinic, we understand the importance of finding a reliable and experienced cardiologist. This is why we have created this guide to help you understand the services and expertise of Dr. Sudheer Koganti, the best heart doctor in Hyderabad and Gachibowli.

Who is Dr. Sudheer Koganti?

Dr. Sudheer Koganti is an accomplished cardiologist with extensive experience in diagnosing and treating heart conditions. He has a keen interest in interventional cardiology and specializes in coronary angioplasty, stenting, and structural heart interventions.

Dr. Koganti obtained his medical degree from the prestigious Osmania Medical College in Hyderabad. He later pursued his post-graduation in General Medicine and Cardiology from the esteemed Nizam's Institute of Medical Sciences, Hyderabad.

With over 15 years of experience in cardiology, Dr. Sudheer Koganti is considered one of the best cardiologists in Hyderabad. He is currently practicing at Sunshine Hospitals, Hyderabad, and has performed over 10,000 cardiac interventions to date.

Services offered by Dr. Sudheer Koganti

As a leading cardiologist in Gachibowli and Hyderabad, Dr. Sudheer Koganti provides a wide range of cardiac services to his patients. Some of the services offered by him include:

Coronary Angioplasty and Stenting: Dr. Koganti specializes in performing coronary angioplasty and stenting to treat coronary artery disease. He uses advanced techniques and technologies to ensure that the procedure is safe and effective.

Structural Heart Interventions: Dr. Sudheer Koganti has expertise in performing structural heart interventions, such as TAVI, MitraClip, and ASD/PFO closures. These procedures are minimally invasive and have a shorter recovery time than traditional surgeries.

Pacemaker and ICD Implantation: Dr. Koganti is proficient in implanting pacemakers and ICDs to treat heart rhythm disorders. He uses the latest technology and techniques to ensure that the implantation is successful and the patient's recovery is smooth.

General Cardiology Consultation: Dr. Sudheer Koganti provides comprehensive general cardiology consultations to his patients. He performs various diagnostic tests, such as ECG, Echo, and TMT, to evaluate the patient's heart health and provides personalized treatment plans based on their condition.

Why choose Dr. Sudheer Koganti as your heart specialist?

Experience: Dr. Sudheer Koganti has over 15 years of experience in cardiology and has performed over 10,000 cardiac interventions to date. This makes him one of the most experienced cardiologists in Hyderabad.

Expertise: Dr. Koganti has a keen interest in interventional cardiology and specializes in performing coronary angioplasty, stenting, and structural heart interventions. He uses advanced techniques and technologies to ensure that the procedures are safe and effective.

Patient-Centric Approach: Dr. Sudheer Koganti believes in providing personalized care to his patients. He takes the time to understand their condition, explains the treatment options, and helps them make informed decisions about their health.

State-of-the-art Infrastructure: Dr. Koganti practices at Sunshine Hospitals, Hyderabad, which is a state-of-the-art facility equipped with the latest medical technology and equipment. This ensures that the patients receive the best possible

Dr. Sudheer Koganti is a renowned Heart Specialist in Hyderabad, with expertise in Interventional Cardiology. He is widely recognized as one of the best Interventional Cardiologists in Hyderabad, as well as in the Gachibowli area.

With years of experience in the field of Cardiology, Dr. Sudheer Koganti has established himself as a top Cardiologist in Hyderabad, known for his exceptional skills and compassionate care. He is a highly sought-after Cardiac Surgeon in Hyderabad, known for his expertise in performing complex surgeries with precision and success.

If you are looking for the best Cardiologist Doctor in Hyderabad, you can trust Dr. Sudheer Koganti to provide you with the highest quality of care. His patient-centric approach and dedication to delivering the best outcomes have earned him a reputation as one of the most famous Cardiologists in Hyderabad.

Whether you are suffering from a heart condition or require preventive care, Dr. Sudheer Koganti can provide you with personalized treatment plans tailored to your unique needs. With his vast experience and expertise in the field of Cardiology, he can accurately diagnose and treat a wide range of cardiac conditions, including heart attacks, arrhythmias, heart failure, and more.

Best Cardiologist Doctor in Hyderabad

If you are seeking the services of a top Cardiologist in Hyderabad, look no further than Dr. Sudheer Koganti. He is committed to providing the best possible care to his patients and helping them lead healthier, happier lives.

Dr. Sudheer Koganti specializes in the treatment of a wide range of heart conditions, including Aortic Regurgitation, Bicuspid Aortic Valve Disease, Supraventricular Tachycardia, and Coronary Artery Disease. He is highly skilled in providing medical treatments for these conditions, as well as in performing complex procedures like Aortic Regurgitation Valve Replacement.

Aortic Regurgitation is a condition where the aortic valve in the heart does not close properly, causing blood to flow back into the heart. Dr. Sudheer Koganti is an expert in providing medical treatment for Aortic Regurgitation, as well as in performing surgical interventions like Aortic Regurgitation Valve Replacement.

Bicuspid Aortic Valve Disease is a congenital heart condition that affects the aortic valve, causing it to narrow or leak. Dr. Sudheer Koganti is highly skilled in providing medical treatment for Bicuspid Aortic Valve Disease, as well as in performing surgical interventions like valve repair or replacement.

Supraventricular Tachycardia is a condition where the heart beats too quickly, often causing symptoms like dizziness, shortness of breath, and chest pain. Dr. Sudheer Koganti is an expert in providing medical treatment for Supraventricular Tachycardia, including the use of medications or minimally invasive procedures like catheter ablation.

Coronary Artery Disease is a condition where the arteries that supply blood to the heart become narrowed or blocked, leading to chest pain, shortness of breath, and other symptoms. Dr. Sudheer Koganti is highly skilled in providing medical treatment for Coronary Artery Disease, including the use of medications, lifestyle changes, and procedures like angioplasty or stenting.

In addition to his expertise in the treatment of heart conditions, Dr. Sudheer Koganti is affiliated with the Best Cardiology Hospital in Hyderabad, providing his patients with access to state-of-the-art facilities and the latest advancements in cardiac care.

In conclusion, Dr. Sudheer Koganti is the Best Cardiologist Doctor in Hyderabad, known for his expertise in Interventional Cardiology and his patient-centric approach to care. Whether you require preventive care or treatment for a heart condition, Dr. Sudheer Koganti can provide you with personalized treatment plans tailored to your unique needs you are searching for the Best Heart Specialist in Hyderabad, look no further than Dr. Sudheer Koganti. With his extensive experience and expertise in the field of Cardiology, he has earned a reputation as one of the top Cardiologists in the city.

[abheartcarenew]

Comprehensive guide to Minimally Invasive Heart Surgery

Minimally Invasive Heart Surgery

To keep the heart functioning, a tremendous amount of effort is needed. Minimally invasive cardiac surgery is one of the most recent developments in the field of a healthy heart. The procedure is risk-free and has no significant negative effects. Let's continue and quickly go over the procedure.

Many years ago, heart surgery is performed with a bigger midline incision and breast bone cutting (sternum). Although this strategy provided good exposure and convenience of operation, it is now time for evolution due to advances in technology and tools.

The minimally invasive technique will develop and grow as technology improves and surgeons' experience increases around the world. Patients who believe that MICS techniques lessen surgical stress will select more long-lasting surgical choices. Due to the clear potential benefits of an early return to regular activities and increased quality of life, patients are more likely to request MICS methods in the future for their cardiac problems. For the greatest results, heart teams from various centres will collaborate in hybrid operating rooms.

What is minimally invasive heart surgery?

The term "Minimally Invasive Heart Surgery" refers to treatments done on the heart using one or more tiny incisions (incisions). Open-heart procedures, on the other hand, often involve a single, lengthy incision down the front of your chest.

Through the incisions, surgeons insert small, powerful cameras, equipment, or robotic arms. To reach your heart, the surgeon inserts tools between your ribs. Compared to open cardiac surgeries, minimally invasive procedures might result in less scarring, less pain, and quicker healing. In order to access your heart during an open-heart surgery, your breastbone (sternum) must be sliced.

What are the types of minimally invasive heart surgery?

There are two main types of minimally invasive heart surgery:

Thoracoscopic surgery: One or more tiny incisions are made on the side of your chest by the surgeon. Through the cuts, a thoracoscope (a long tube with a video camera) is inserted to observe your heart. They use long, thin tools to operate.

A small incision is made on the side of your chest during robotically assisted heart surgery. Through the cuts, they direct robotic arms. Your surgeon operates the robotic arms to carry out the treatment while the robot displays clear views of your heart.

What is minimally invasive heart surgery used for?

Surgeons may use minimally invasive techniques for a variety of surgeries, including:

Atrial septal defect (ASD) closure.

Atrioventricular canal defect surgery.

Cardiac tumor removal.

Coronary artery bypass surgery.

Maze procedure for atrial fibrillation.

Patent foramen ovale (PFO) closure.

Valve repairs or replacements, including minimally invasive mitral valve repair.

Ventricular assist device placement.

Is minimally invasive heart surgery safe?

Yes. There is a risk of complications with any type of surgery. However, minimally invasive surgeries often have lower complication rates than open procedures.

What happens before minimally invasive heart surgery?

You'll receive instructions from your surgeon on how to be ready for minimally invasive cardiac surgery. Some drugs you may need to temporarily cease using before to the surgery.

To keep you sleeping throughout the procedure, general anaesthetic will be administered. Your surgeon may decide to shave a little section of your hair where the incisions will be made. You will be connected to a heart-lung machine by your surgical team, which maintains your blood pumping throughout the procedure.

How long does minimally invasive heart surgery take?

Minimally invasive heart surgery usually takes about two to six hours.

What happens after minimally invasive heart surgery?

After minimally invasive heart surgery, you'll normally stay in the intensive care unit (ICU) for one to two days. To avoid fluid accumulation around your heart, you might have drainage tubes in your chest.

You will continue to heal for a few more days in a different hospital area. Within a day or two of surgery, your medical team will assist you in standing up and walking. They could advise you to practise breathing exercises to prevent fluid from entering your lungs. People typically stay in hospitals for a few days. The particular disease you have and the kind of surgery you undergo will determine how long you spend overall in the hospital.

What are the advantages of minimally invasive heart surgery?

Faster recovery.

Less blood loss.

Less visible scars.

Lower risk of bleeding or infection.

Reduced pain.

Shorter hospital stays.

Minimally invasive heart surgery has a lower risk of complications than open-heart surgery. But there's still a risk of:

Bleeding.

Infection.

Irregular heartbeats (arrhythmias).

Stroke.

This isn’t common, but it’s important to understand that it’s possible.

How long does it take to recover from minimally invasive heart surgery?

For a few weeks following surgery, you could feel more exhausted than usual. You'll receive instructions from your surgeon regarding when you can resume driving, working, and other activities. Within two to four weeks, most people can resume their regular activities. For several weeks, you must refrain from doing any hard lifting.

To safely raise your exercise levels, your doctor could also advise that you finish a cardiac rehabilitation course. These programmes might also assist you in developing better routines, such regular exercise and a heart-healthy diet.

When should I see my healthcare provider?

See your healthcare provider right away if you experience any signs of complication after minimally invasive heart surgery, including:

Drainage or pus around the incision site.

Excessive swelling or redness around the incision site.

Fever or chills.

Heart palpitations.

Unusual swelling or fluid retention (edema) in your legs or feet.

Weight gain of more than three pounds in one week.

Conclusion 

Minimally invasive heart surgeries are operations that surgeons perform through one or more small incisions in your chest. These procedures are less invasive than open-heart surgeries. Open-heart surgeries use one long incision down the center of your chest. Surgeons may use minimally invasive techniques to repair heart valves, remove tumors or correct heart defects. Minimally invasive heart surgery often leads to less pain, smaller scars and faster recovery.

[mcatmemoranda]

Ok. I thought I understood ASD and PFO, but now I'm just confused. Someone posted this to Piazza.

An ASD is a failure of the septal tissue to form between the atria, and as such it is considered a congenital heart defect, something that you are born with. Generally an ASD hole is larger than that of a PFO. The larger the hole, the more likely there are to be symptoms.

PFOs, on the other hand, can only occur after birth when the foramen ovale fails to close. The foramen ovale is a hole in the wall between the left and right atria of every human fetus. This hole allows blood to bypass the fetal lungs, which cannot work until they are exposed to air. When a newborn enters the world and takes its first breath, the foramen ovale closes, and within a few months it has sealed completely in about 75 percent of us. When it remains open, it is called a patent foramen ovale, patent meaning open. For the vast majority of the millions of people with a PFO, it is not a problem, even though blood is leaking from the right atrium to the left. Problems can arise when that blood contains a blood clot."

Found this on American Heart Association, link: http://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/patent-foramen-ovale-pfo

It seems ASD missing actual tissue in utero vs. failure of closure of structures once born in PFO. I like to look at the basics when first learning, so hope this helps if still confused!

I think I'm just going to go to Dr. Solounias or one of the anatomy lecturers and ask. But to be very simple: ASD = congenital heart disease; there is missing tissue. PFO = the foramen ovale doesn't close postpartum; since it occurs postpartum, it's not a problem that occurred in utero; not a CHD.

My question is: how can there be an opening between the two atria if the problem is only with the septum primum and the ostium secundum? Because in order for there to be an opening between the atria, there has to be an opening between the septum secundum and the endocardial cushion... Is it that a "PFO" isn't an actual PFO without the ASD secundum? I think maybe that's. Maybe there can be a maintained small opening between the septum secundum and the endocardial cushion. But it wouldn't be called a PFO unless the ostium secundum didn't close.

[nssrdigitalinfotechstuff]

Interventional cardiologist in vijayawada - Dr. Vamsi Krishna

Dr.Vamsi Krishna is a Senior Consultant Interventional cardiologist in vijayawada. We provide the best treatment for cardiac diseases Interventional cardiologist in Vijayawada – Dr.vamsi krishna Interventional cardiology – all you need to know

With the rising number of cardiovascular ailments, treatments have also evolved. One such subspecialty of general cardiology is interventional cardiology. It covers a wide range of cardiac conditions. Moreover, it also offers numerous heart disease treatments. Do you want to get the best interventional treatment? In that case, you must visit Vamsi Heart Care. It boasts of an excellent interventional cardiologist in Vijayawada.

What is interventional cardiology? Interventional cardiology focuses on the usage of catheter-based treatments for different heart diseases. Here, the catheter is used for the treatment of vascular disease, coronary artery disease, congenital heart defects, structural heart disease, etc.

Interventional cardiologists use a wide variety of diagnostic tools to understand different cardiovascular functions. It is imperative to comprehend that interventional cardiologists do not conduct open-heart surgical operations.

Moreover, interventional cardiologists use the latest cutting-edge technology and recent techniques. For instance, they opt for transcatheter aortic valve replacement or TAVR, cardiac catheterization, mitral valve replacement, etc.

General cardiologists are not trained to perform these complex techniques. Interventional cardiologists need to undergo specialized training to conduct such critical surgeries.

interventional cardiologist in Vijayawada Different conditions that interventional cardiology treats There are numerous conditions that come under the treatment of interventional cardiology. These include –

Angiogenesis Angioplasty and stent placement Aortic diseases and dissection Transcatheter aortic valve replacement (TAVR) Atrial septal defect (ASD) Cardiovascular disease Carotid artery angioplasty and stenting Carotid artery disease Congenital heart disease Congestive heart failure Coronary angioplasty and stenting Coronary artery disease (CAD) Gene therapy Heart attack Heart valve disease Hypertrophic cardiomyopathy Invasive cardiology Left ventricular assist device (LVAD) Non-invasive cardiology Patent foramen ovale (PFO) Percutaneous coronary intervention (PCI) Percutaneous valve repair Peripheral artery disease (PAD) Preventive cardiology Renovascular disease Sports medicine, cardiology Structural heart disease Procedures and tests

Interventional cardiologists conduct multiple procedures and tests in order to reach an accurate diagnosis. With technological advancements in the medical field, interventional cardiology can now utilize the latest diagnostic processes. This aids in offering the best care to fragile and high-risk patients. Some of the tests that Interventional cardiologists perform are –

CCT or Cardiac computed tomography DSA or Digital subtraction angiography Coronary angiography Echocardiogram MRI or Magnetic resonance imaging Intravascular ultrasound MPI or Myocardial perfusion imaging Different procedures that interventional cardiologists conduct includes –

Angioplasty Atrial septal defect closure Alcohol septal ablation Cardiac catheterization Aortic balloon valvuloplasty Mitral balloon valvuloplasty Carotid artery stenting Directional coronary atherectomy Peripheral vascular interventions Exercise stress test Percutaneous coronary interventions Stenting Percutaneous valve repair Ventricular septal defect repair TAVR or Transcatheter aortic valve replacement These are some of the tests and procedures that interventional cardiologists perform to ensure that they get accurate information. After observing the results, the medical professionals map out a specific palm to treat the diseases.

Future of interventional cardiology

The future of interventional cardiology is bright. With constant changes in the field along with the introduction of new technology and devices, one can expect more complex solutions. Apart from that, clinical trials based on unique interventional cardiology procedures are also bearing fruitful results. One of the most popular and successful interventional cardiology treatments includes transcatheter mitral valve replacement and transcatheter aortic valve replacement. These less-invasive treatments have benefitted the old-aged and high-risk patients the most. More research on this field will yield more positive results, giving rise to much more innovative cardiovascular solutions.

Conclusion

Having a basic understanding of interventional cardiology is extremely useful. That way, you can at least understand if you need a consultation from the best interventional cardiologist in Vijayawada. For excellent medical solutions, you can come to Vamsi Heart Care. Here, you will get top-notch heart care services at affordable price rates.

[advancedcardiodr]

Advanced Cardiovascular Care Center | Best Cardiologists in Houston

Advanced Cardiovascular Care Center

Advanced Cardiovascular Care Center offers cardiac services in a warm, comforting, relaxing atmosphere. The practice is committed to high-quality patient care in an ever-changing healthcare environment.

The practice operates under the direction of Dr. Annie Varughese, Board-Certified in Cardiology and leading cardiology specialist providing treatment for heart attacks, angina, hypertension and all aspects of cardiology. The well-trained cardiology staff offers a variety of comprehensive, state-of-the-art services to diagnose, treat and manage heart disease. Our cardiac specialists improve the lives of thousands of patients every year using advanced surgical and non-surgical procedures.

The goal is to provide state-of-the-art cardiology care in a personal setting for our patients. We provide information for you and your family so you can understand the problem, tests, and any recommended treatments.

We thank you for selecting Advanced Cardiovascular Care Center for you or your loved ones. We appreciate any suggestions about how we might improve our service for you.

Services Offered byAdvanced Cardiovascular Care Center

·         Diagnostic Tests

·         Echocardiography

·         EKG

·         Echocardiogram

·         Carotid Ultrasound

·         Stress Echo

·         Nuclear Stress Test

·         Holter-Event Monitor

·         Transesophageal ECHO

·         External Counterpulsation Therapy(EECP)

·         Tilt Table

·         Peripheral Angiography and Stenting

·         Cardiac Catheterization and Stenting

·         Carotid Stenting

·         PFO & ASD Closure

·         Cardiac MRI/Coronary CTA

·         Advanced Lipid Test

·         Weight Loss Therapy

·         Consult

·         Routine Physicals

·         Well Women Exams

·         Presurgical Clearance

·         Echo

·         Advanced Lipid Insulin

·         Nutrition Counseling

·         Genetic Testing for Coronary Disease

·         Pacemakers Defibrillators

·         Peripheral Doppler, Angiography & Stenting

To get the services from the best cardiologists of Houston click on the above links and request an appointment.

[cardiologist-1589254]

Interventional Cardiology: Procedures and Benefits

Interventional cardiology is a subspecialty of cardiology that focuses on minimally invasive procedures to diagnose and treat various heart conditions. These procedures offer numerous benefits compared to traditional open-heart surgery and can significantly improve a patient's quality of life.

Here are some common interventional cardiology procedures and their benefits:

Angioplasty and Stenting: Angioplasty involves the insertion of a tiny balloon into a narrowed or blocked coronary artery to widen it and restore blood flow. Often, a stent (a small mesh tube) is placed to keep the artery open. This procedure can relieve chest pain, improve blood flow, and reduce the risk of heart attack.

Coronary Artery Disease (CAD) Diagnosis: Procedures like coronary angiography and fractional flow reserve (FFR) measurements help cardiologists diagnose CAD, allowing for timely intervention and treatment planning.

Transcatheter Aortic Valve Replacement (TAVR): TAVR is used to treat aortic valve stenosis, a condition where the aortic valve narrows, reducing blood flow from the heart. TAVR is less invasive than open-heart surgery, resulting in shorter hospital stays and quicker recovery.

Atrial Septal Defect (ASD) and Patent Foramen Ovale (PFO) Closure: These procedures close abnormal openings in the heart, preventing blood from flowing where it shouldn't. They reduce the risk of stroke and improve overall heart function.

Cardiac Catheterization: This diagnostic procedure helps assess the condition of the coronary arteries, heart chambers, and valves. It provides valuable information for treatment decisions and is less invasive than surgical alternatives.

Peripheral Artery Disease (PAD) Interventions: Interventional cardiology can address blockages in peripheral arteries, improving blood flow to the legs and reducing pain and mobility issues.

Benefits of interventional cardiology include shorter recovery times, less pain, lower infection rates, and reduced risk of complications compared to traditional surgery. These procedures are often performed using small incisions or catheters, minimizing trauma to the body and resulting in faster healing.

Interventional cardiology has revolutionized the treatment of heart conditions. These minimally invasive procedures offer patients not only improved outcomes but also a better quality of life, allowing them to return to their daily activities sooner and with less disruption. If you or a loved one has heart-related concerns, consult with the best cardiologist near Sadar to explore the potential benefits of interventional cardiology for your specific condition.

[sporadicfacecollectorus-blog]

Heart Defect Closure Device Market Is Projected To Register A Moderate Growth During The Forecast Period 2020

Heart defects are associated with the structure of the heart. When any defect appears in the structure of the heart, it disrupts the normal flow of blood through the heart. The blood flow can slow down and sometimes flow in the wrong direction or to the wrong place and blocked completely. Sometimes, many heart defects are present at birth. For instance, congenital heart defect (CHD) is the most common type of birth defect. Some CHDs also cause heart block. Heart block is one of the severe medical conditions that occur with the heart's electrical system. This electrical system controls the rate and rhythm of heartbeats. These types of heart defects require specific heart closure devices for their treatment.

Request For Sample : https://www.persistencemarketresearch.com/samples/3241

The global heart closure device market is categorized based on the different types of heart defects. Some of the major heart defects are Left Atrial Appendage (LAA), Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD) and Patent Ductus Arteriosus (PDA).

In terms of geographic, North America dominates the global heart closure device market. The U.S. represents the largest market for heart defect closure device followed by Canada in North America. However, Asia is expected to show high growth rates in the next five years in global heart defect closure device market due to increasing aging population. Older people are more susceptible towards heart stroke than adults. This would increase the demand of heart closure devices for their treatment. China and India are expected to be the fastest growing heart defect closure device markets in Asia.

In recent time, rising number of arterial fibrillation patients and increasing incidence of CHDs are some of the major drivers for global heart defect closure device market. Increasing incidence of CHDs and rising number of arterial fibrillation patients have led to the demand heart defect closure devices for their treatment. In addition, advancement in heart closure device technology is also fueling the growth of the global heart defect closure device market. However, stringent regulations and high cost involved in manufacturing of devices are some of the key restraints for global heart defect closure device market. In addition, high risk of complications associated with treatment also hampers the growth of global heart defect closure device market.

Request For TOC : https://www.persistencemarketresearch.com/toc/3241

Some of the major companies operating in the global heart defect closure device market are Boston Scientific Corp., W.L. Gore and Associates Inc., St. Jude Medical Inc., Biosense Webste, Cardia Inc., LifeTech Scientific, Maquet Cardiovascular, Medtronic, Occlutech Holding AG and Pfm medical.

[surajpalange-blog]

Global Heart Defect Closure Devices Market 2019-2023

AF is the most commonly encountered arrhythmia in clinical practice. It is associated with increased morbidity, especially stroke and heart failure, and mortality. AF is becoming a major public health burden across the world, and its prevalence is expected to increase due to the rapidly growing geriatric population, especially in developing countries. Other risk factors of AF such as high blood pressure (BP), obesity, diabetes, heart failure, ischemic heart disease, chronic kidney disease (CKD), and the heavy consumption of alcohol are also on the rise. Hence, the rising prevalence of AF will increase the demand for LAA closure therapy. Which will drive the growth of the global heart defect closure devices market. Our analysts have predicted that the heart defect closure devices market will register CAGR of over 29% by 2023.

 Request Sample Report @ https://www.acquiremarketresearch.com/sample-request/718

 Market Overview

Technological advances in heart defect closure

There had been several significant technological advances in all forms of cardiovascular care. Especially in the treatment of structural heart disease, in the last decade. The advances in catheterization techniques, medical imaging, and devices have increased the adoption of minimally invasive procedures. Therefore, interventional cardiology procedures have now become the standard of care to treat ASD and PFO.

Shortage of skilled surgeons to perform heart defect closure procedures

There is a global shortage of cardiologists, including general cardiologists, electrophysiologists: interventional cardiologists, both coronary and peripheral, and pediatric cardiologists. This shortage is attributed to the aging cardiology community, limited growth in fellowship positions, increasing burden of cardiovascular diseases (CVDs): and evolving Medical Devices & Consumables reforms.

For the detailed list of factors that will drive and challenge the growth of the heart defect closure devices market during the 2019-2023, view our report.

 Competitive Landscape

The market appears to be moderately concentrated and with the presence of few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the markets competitive landscape and offering information on the products offered by companies.

 More Info and TOC @ https://www.acquiremarketresearch.com/industry-reports/global-heart-defect-closure-devices-market-2019-2023/718/

 Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

- 2.1 Preface

- 2.2 Preface

- 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

- Market ecosystem

- Market characteristics

- Market segmentation analysis

PART 04: MARKET SIZING

- Market definition

- Market sizing 2018

- Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

- Bargaining power of buyers

- Bargaining power of suppliers

- Threat of new entrants

- Threat of substitutes

- Threat of rivalry

- Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

- Market segmentation by product

- Comparison by product

- LAA closure devices - Market size and forecast 2018-2023

- PFO closure devices - Market size and forecast 2018-2023

- ASD closure devices - Market size and forecast 2018-2023

- Other heart defect closure devices - Market size and forecast 2018-2023

- Market opportunity by product

 Request for Discount @ https://www.acquiremarketresearch.com/discount-request/718

 About Acquire Market Research: Acquire Market Research is a shrine of world-class research reports from around the world and we offer you only the best in the Industry when it comes to research. At Acquire, every data need will be catered to and met with a powerful world of choices. "We understand the integral role data plays in the growth of Business empires."

Contact Us: 555 Madison Avenue, 5th Floor, Manhattan, New York, 10022 USA Phone No.: +1 (800) 663-5579 Email ID:sales@acquiremarketresearch.com

[pavanghage]

Heart Defect Closure Devices Market Research Insights 2021, Size, Share, Trends, Competitive Landscape, and COVID-19 Impact Forecast till 2025

"

Heart Defect Closure Devices Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.

Sample Copy of This Report:https://axelreports.com/request-sample/144676

A 360 degree outline of the competitive scenario of the Global Heart Defect Closure Devices Market is presented by Axel Reports Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Reasons for buying this report:

It offers an analysis of changing competitive scenario.

For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.

It offers seven-year assessment of Global Heart Defect Closure Devices

It helps in understanding the major key product segments.

Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.

It offers regional analysis of Global Heart Defect Closure Devices Market along with business profiles of several stakeholders.

It offers massive data about trending factors that will influence the progress of the Global Heart Defect Closure Devices

Get ToC for the overview of the premium report @ https://axelreports.com/industry-analysis/global-heart-defect-closure-devices-industry-research-report-2021-segmented-by-major-market/144676

By Market Verdors: Abbott Coherex Medical Lepu Medical Boston Scientific Starway LifeTech MicroPort W. L. Gore and Associates Occlutech Cardia By Types: ASD Closure Devices VSD Closure Devices PDA Closure Devices PFO Closure Devices LAA Closure Devices By Applications: Hospitals Clinics

A detailed outline of the Global Heart Defect Closure Devices Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Heart Defect Closure Devices Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Heart Defect Closure Devices Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Heart Defect Closure Devices Market. The feasibility of the new report is also measured in this research report.

Make an Enquiry for purchasing this Report :https://axelreports.com/enquiry-before-buying/144676

Table of Contents:

Global Heart Defect Closure Devices Market Overview

Economic Impact on Industry

Market Competition by Manufacturers

Production, Revenue (Value) by Region

Production, Revenue (Value), Price Trend by Type

Market Analysis by Application

Cost Analysis

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Heart Defect Closure Devices Market Forecast

ABOUT US:

Axel Reports has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact: Axel Reports Akansha G (Knowledge Partner) Office No- B 201 Pune, Maharashtra 411060 Phone: US +18488639402 Email: sales@axelreports.com/ Web: https://axelreports.com/

"

[atomicjellyfishdelusion]

Structural Heart Devices Market  to Register Exponential Growth During COVID-19 Pandemic

Structural heart disease refers to non-coronary cardiovascular disease processes, like heart valve repair and replacement, left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs and PFOs. From the last 10 years, tremendous growth have been noticed in Structural heart devices market. Most of these procedures are based on catheter and wire manipulation. With increasing population, and growing health awareness among people, the Structural Heart Disease Market is expected to expand at a very high rate.

Request For Report Sample@ https://www.trendsmarketresearch.com/report/sample/3078

The structural heart devices market are categorized into the following segments and subsegments: o the basis of product: Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Other Devices, Accessories; on the basis of procedure: Replacement Procedures, TAVR Procedures, SAVR Procedures, Repair Procedures, Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures; on the basis of geography: North America, Europe, Asia Pacific, Rest of the World.In every country, the risk of cardiovascular diseases is increasing with the aging of the growing population. Due to pollution and bad living habits, the cardiovascular diseases including structural heart diseases have become leading cause of death, now a days. These factors are the key growth drivers of the Structure Heart Devices Market and will keep taking the market to new heights.

The major restraints include the lack of availability of skilled cardiovascular Interventionist. Another factors include inaccessibility and high cost of devices. These factors are slowing the growth of the market. Whereas the increasing health awareness is helping in the growth of market and also the hospitals are these days following the international standards for these cardiovascular diseases.Among all the segments, Occluders and Delivery Systems are having the largest market share. With the growing population, pollution is also increasing which in turn caused the scarcity of purified drinking water and adulteration of food.

Get Complete TOC with Tables and Figures@ https://www.trendsmarketresearch.com/report/discount/3078

These adulterations are the main causes for the increasing risk of cardiovascular diseases. Deposition of cholesterol in the vessels are the most common problem these days, which require catheter and wire strands.Geographically, North America has most lucrative market, and is progressing day by day. Sedentary lifestyle is flourishing in the Western culture due to advancement in the technology. These factors lead to the cardiovascular diseases. Continuous Research and Development are going in this region at high rate. Asia Pacific region market is the next huge market after North America due to growing population and technological progress.

Some of the major key players include: Edwards Lifesciences Corporation, Medtronic plc, Abbott, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Micro Interventional Devices, Inc., Braile Biomédica, Lepu Medical Technology Company Ltd., TTK Healthcare Limited.

<<< Get COVID-19 Report Analysis >>> https://www.trendsmarketresearch.com/report/covid-19-analysis/3078

[bestreports]

Global Heart Defect Closure Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2028

JULY 03, 2019: The global Heart Defect Closure Devices market was valued at $XX million in 2018, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

To Request A Sample Copy Of This Report @:   https://www.radiantinsights.com/research/2013-2028-report-on-global-heart-defect-closure-devices-market/request-sample

This report provides detailed historical analysis of global market for Heart Defect Closure Devices from 2013-2018 and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Heart Defect Closure Devices market.

To Browse Full Research Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-heart-defect-closure-devices-market

Leading players of Heart Defect Closure Devices including:

·         Abbott

·         Boston Scientific

·         LifeTech

·         Lepu Medical

·         Occlutech

·         W. L. Gore and Associates

·         Starway

·         Coherex Medical

·         Cardia

·         MicroPort

Market split by Type, can be divided into:

·         ASD Closure Devices

·         VSD Closure Devices

·         PDA Closure Devices

·         PFO Closure Devices

·         LAA Closure Devices

Market split by Application, can be divided into:

·         Hospitals

·         Clinics

Market split by Sales Channel, can be divided into:

·         Direct Channel

·         Distribution Channel

Market segment by Region/Country including:

·         North America (United States, Canada and Mexico)

·         Europe (Germany, UK, France, Italy, Russia and Spain etc.)

·         Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

·         South America Brazil, Argentina, Colombia and Chile etc.)

·         Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Table of Contents

Chapter 1 Heart Defect Closure Devices Market Overview

1.1 Heart Defect Closure Devices Definition

1.2 Global Heart Defect Closure Devices Market Size Status and Outlook (2013-2028)

1.3 Global Heart Defect Closure Devices Market Size Comparison by Region (2013-2028)

1.4 Global Heart Defect Closure Devices Market Size Comparison by Type (2013-2028)

1.5 Global Heart Defect Closure Devices Market Size Comparison by Application (2013-2028)

1.6 Global Heart Defect Closure Devices Market Size Comparison by Sales Channel (2013-2028)

1.7 Heart Defect Closure Devices Market Dynamics

To See More Reports of This Category by Radiant Insights: https://www.radiantinsights.com/catalog/medical-devices

About Radiant Insights: Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact: Company Name: Radiant Insights, Inc Contact Person: Michelle Thoras Email: sales@radiantinsights.com Phone: (415) 349-0054 Address: 201 Spear St #1100, Suite #3036 City: San Francisco State: California Country: United States For more information, Visit: http://www.radiantinsights.com